Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.6K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

19
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
19
Teratogenicity01:07

Teratogenicity

4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Rh Blood Group01:19

Rh Blood Group

4.2K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.2K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2025 AAHA One Health Guidelines: Navigating Cross-Disciplinary Partnerships.

Journal of the American Animal Hospital Association·2025
Same author

Unit-Based Nurses' Development of a Couplet Care Acuity Scoring Tool.

Nursing for women's health·2024
Same author

Acuity Tools for the Antepartum and Neonatal Intensive Care Units.

MCN. The American journal of maternal child nursing·2022
Same author

Nurses' Experiences of "Being Swamped" in the Clinical Setting and Association with Adherence to AWHONN Nurse Staffing Guidelines.

MCN. The American journal of maternal child nursing·2020
Same author

Sepsis in Obstetrics: Pathophysiology and Diagnostic Definitions.

MCN. The American journal of maternal child nursing·2017
Same author

Sepsis in Obstetrics: Treatment, Prognosis, and Prevention.

MCN. The American journal of maternal child nursing·2017
Same journal

An Integrative Review of Structural Interventions to Address Inequity in the Maternal Mortality Crisis Among Black Birthing People.

Nursing for women's health·2026
Same journal

Efficacy of Virtual Reality Glasses on Anxiety, Physiologic Parameters, and Satisfaction Among High-Risk Pregnant Women Undergoing Nonstress Testing: A Quasi-Experimental Study.

Nursing for women's health·2026
Same journal

Optimization of an Instrument for Screening Complicated Grief After Reproductive Loss.

Nursing for women's health·2026
Same journal

An Examination of Throughput Issues in Inpatient Obstetrics Units in an Academic Medical Center.

Nursing for women's health·2026
Same journal

Experiences and Factors Associated With Exclusive Breastfeeding Among Women With Postpartum Depression.

Nursing for women's health·2026
Same journal

Gender, Having Young Children, and Contexts of Unfair Treatment Within the First 2 Years After Birth.

Nursing for women's health·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.7K

HIV in Pregnancy.

Cheryl Roth1, Pauline F Hrenchir1, Christine J Pacheco1

  • 1HonorHealth Scottsdale Shea in Scottsdale, AZ.

Nursing for Women'S Health
|February 24, 2016
PubMed
Summary
This summary is machine-generated.

Women with HIV can now make informed reproductive choices thanks to advances in antiretroviral therapy. Understanding HIV in pregnancy is crucial for perinatal nurses managing maternal and fetal health.

Keywords:
HIVantiretroviral therapyhuman immunodeficiency viruspregnancy

More Related Videos

Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
05:22

Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface

Published on: December 30, 2025

337
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.3K

Related Experiment Videos

Last Updated: Mar 25, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.7K
Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface
05:22

Ex vivo Culture of Human Placental Explants for the Study of Viral Transmission Across the Maternal-Fetal Interface

Published on: December 30, 2025

337
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.3K

Area of Science:

  • Reproductive Health
  • Infectious Diseases
  • Perinatal Care

Background:

  • Antiretroviral therapy has improved options for women with HIV regarding reproduction.
  • HIV-positive women are increasingly considering pregnancy.
  • Perinatal nurses require updated knowledge on HIV management during pregnancy.

Purpose of the Study:

  • To inform perinatal nurses about maternal and fetal implications of HIV in pregnancy.
  • To outline treatment parameters and drug regimens for HIV in pregnancy.
  • To support informed reproductive decision-making for HIV-positive women.

Main Methods:

  • Literature review on current antiretroviral therapies.
  • Analysis of treatment guidelines for antepartum, intrapartum, and postpartum periods.
  • Synthesis of information on maternal and fetal outcomes in HIV-positive pregnancies.

Main Results:

  • Antiretroviral therapy significantly reduces perinatal HIV transmission.
  • Specific drug regimens are recommended throughout pregnancy and postpartum.
  • Maternal and fetal health monitoring is essential.

Conclusions:

  • Effective management of HIV in pregnancy is achievable with current therapies.
  • Perinatal nurses play a vital role in supporting HIV-positive women and their infants.
  • Informed reproductive choices are empowered by understanding HIV management during pregnancy.